SCHEMBL7243742

SCHEMBL7243742

Cc1ccc(N2CCN(c3ncccc3C(=O)NC(=O)CCc3ccccc3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.53
HSD17B10 Q99714 1/20 0.53
CAPN1 P07384 1/20 0.52
CTSS P25774 1/20 0.52
KCNH2 Q12809 2/20 0.47
CHIA Q9BZP6 1/20 0.47
MAPT P10636 7/20 0.45
NPC1 O15118 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
GLA P06280 1/20 0.42
ME2 P23368 1/20 0.42
ME1 P48163 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243837 0.93 CAPN1 (0.58) TSHRHSD17B10CAPN1CTSSCHIA
SCHEMBL7242756 0.90 TSHR (0.55) TSHRHSD17B10CAPN1CTSSCHIA
SCHEMBL7232781 0.89 TSHR (0.51) TSHRHSD17B10CAPN1CTSSKCNH2
SCHEMBL7242857 0.88 CHIA (0.61) TSHRHSD17B10CAPN1CTSSCHIA
SCHEMBL7232351 0.86 TSHR (0.58) TSHRHSD17B10CAPN1CTSSCHIA
SCHEMBL7232626 0.86 TSHR (0.53) TSHRHSD17B10CAPN1CTSSCHIA
SCHEMBL7235837 0.85 TSHR (0.56) TSHRHSD17B10CAPN1CTSSCHIA
SCHEMBL7233171 0.82 CAPN1 (0.57) TSHRHSD17B10CAPN1CTSSKCNH2
SCHEMBL7238934 0.79 L3MBTL1 (0.50) TSHRHSD17B10MAPTSMN1; SMN2LMNA
SCHEMBL7238307 0.79 TSHR (0.48) TSHRHSD17B10CAPN1CTSSCHIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed